Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scrip's 2010 Pharma League Tables – Top companies force growth in a pressure cooker environment

This article was originally published in Scrip

Executive Summary

Loss of patent protection, the weaker economy, increased competition from generic products and pricing pressures have produced an environment of constant challenges for the pharma industry. Nevertheless, most of the leading companies in Scrip Intelligence's Pharma League Tables for 2009 found ways to expand in an industry that underwent major restructuring, says IBI principal analyst Ashley Yeo.

You may also be interested in...



German COVID-19 Testing Rate The Envy Of Others, With Demand Set To Climb

Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”

EU Health Innovation Partnership Reflects Medtech’s Role In Unmet Needs

The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase before its launch under Horizon Europe. In Vivo asked the partnership’s medtech industry lead, Patrick Boisseau, to set out the innovation challenges for participants as they address unmet health care needs in Europe.

China’s NMPA Steps Up To The Plate In COVID-19 Fight But Much Is Left To Do

Chinese monitoring of the spread of COVID-19 locally has reported no new cases of home-grown infection in a single day for the first time since the outbreak began. It indicates control efforts, including the NMPA’s fast-tracking of relevant devices, PPE and IVDs, are having the desired effects.

Topics

Related Companies

UsernamePublicRestriction

Register

SC010643

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel